Optimizing Treatment of Metastatic Colorectal Cancer (6/11/14)
You are invited to attend this interactive educational program that is designed to provide busy clinicians with important information and practice tips regarding recent updates in the NCCN guidelines and a forum in which they can discuss cases, data, and best clinical practices with an expert on metastatic colorectal cancer.
The goal of this activity is to improve participants’ competence in implementing the most recent guideline changes and clinical advances in the management of patients with metastatic colorectal cancer.
This program is intended for physicians, registered nurses, pharmacists, and other healthcare professionals who provide care for patients with metastatic colorectal cancer.
Following this program, participants should be able to:
- Select optimal first-line treatment for patients with newly diagnosed metastatic colorectal cancer based on individual patient and tumor characteristics and the extent of disease to improve patient outcomes
- Determine optimal treatment strategies to improve clinical outcomes for patients with metastatic colorectal cancer who progress on first-line therapy
- Manage toxicities related to therapeutic agents used for patients with metastatic colorectal cancer
Alan P. Venook, MD
Madden Family Distinguished Professor of Medical Oncology and Translational Research
Division of Medical Oncology
University of California, San Francisco
San Francisco, California
- 1.00 Participation
- 1.00 Nurse
- 1.00 Pharmacist
- 1.00 Physician